Rare diseases
Investigational molecules
Locations
Back to Germany2 clinical trials in Salzwedel, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer treatments, investigating innovative therapeutic approaches for both early-stage and advanced disease states.
Research emphasizes the evaluation of ribociclib in combination with standard treatments, aiming to improve survival outcomes and develop more effective therapeutic strategies.
Comprehensive analysis of treatment patterns in advanced breast cancer, with particular focus on temporal and molecular responses to targeted therapies.
Studies concentrate on understanding spatial and temporal patterns of treatment efficacy, particularly in the context of first-line therapeutic interventions.
Investigation of dynamic marker-adjusted personalized therapy approaches, comparing various treatment modalities for intermediate-risk breast cancer patients.
Research aims to establish optimal treatment pathways by evaluating both traditional and innovative therapeutic combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
